Trigeminal sensory modulatory effects of galcanezumab and clinical response prediction. Peng KP, Basedau H, Oppermann T, May A, et al. Pain 2022;163:2194-2199.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Peng KP, Basedau H, Oppermann T, May A, et al. Trigeminal sensory modulatory effects of galcanezumab and clinical response prediction. Pain 2022;163:2194-2199.
PMID: 35170575